Available online on 15.07.2022 at http://jddtonline.info
Journal of Drug Delivery and Therapeutics
Open Access to Pharmaceutical and Medical Research
Copyright © 2011-2022 The Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited
Open Access Full Text Article Review Article
The Chemical and Pharmacological Advancements of Quinoline: A Mini Review
Anurag Bharti*, Rohit Kumar Bijauliya, Anita Yadav and Suman
BIU College of Pharmacy, Bareilly International University, Bareilly, UP, India
|
Article Info: _______________________________________________ Article History: Received 13 May 2022 Reviewed 28 June 2022 Accepted 04 July 2022 Published 15 July 2022 _______________________________________________ Cite this article as: Bharti A, Bijauliya RK, Yadav A, Suman, The Chemical and Pharmacological Advancements of Quinoline: A Mini Review, Journal of Drug Delivery and Therapeutics. 2022; 12(4):PageNo. DOI: http://dx.doi.org/10.22270/jddt.v12i4.5561 _______________________________________________ *Address for Correspondence: Anurag Bharti, Lecturer, BIU College of Pharmacy, Bareilly International University, Bareilly, UP, India |
Abstract ___________________________________________________________________________________________________________________ Quinoline is a preferred scaffold that emerges as a prominent assembly motif for the creation of novel pharmacological molecules among heterocyclic compounds. An important family of chemicals includes quinoline and its derivatives that have been studied for various biological activities. Due to its wide range of bioactivity, quinoline, which is made up of benzene fused with N-heterocyclic pyridine, has drawn a lot of interest as a key template in drug creation. In order to demonstrate the quinoline motifs' significant efficacies for upcoming drug development, this review intends to provide the most current developments in chemistry, their medicinal potential, and their pharmacological applications. As a result, these compounds have been produced by several scientific groups as intentional structures, and their biological functions have been examined. The current study offers succinct information on quinoline's natural sources, as well as details on newly marketed medications that include quinoline. The pharmacological effects of quinoline derivatives, such as their anticonvulsant, antibacterial, antiviral, anti-protozoal, antimalarial, anticancer, anti-inflammatory, and anthelmintic properties, are also discussed in this study. Keywords: Nitrogen-Based Heterocycles, Quinoline, Synthesis, Biological Activities |
INTRODUCTION:
Four out of the top five selling medications in the US are believed to include at least one heterocyclic molecule, which has pharmacological properties including antitumor, anticancer, antibacterial, and anti-inflammatory properties. Heterocyclic compounds are essential to many drug core structures as well as biological and pharmacological activities. 1 The relevant heterocycle in this review is quinoline, which is a prime example of a bicyclic heterocyclic molecule. A pyridine ring and a benzene ring fused with two nearby carbons make up the aromatic N-heterocyclic basic chemical known as quinoline. 2 Benzazine, benzo-pyridine, and benzo[b]pyridine are further names for it. 3 Leukol was the name given to the substance when it was first taken out of coal tar by Friedlieb Ferdinand Runge in 1834. The major source of commercial quinoline is still coal tar. 4 Later in 1842, Gerhardt isolated a compound and gave it the name quinoline by dry distilling quinine, strychnine, or cinchonine with alkali. 5
Figure 1: Quinoline Structure
The pKa of pure quinoline, also known as benzo [b] pyridine, in water at 20°C is 4.85. It is an oily, colourless, hygroscopic liquid. Its molecular weight is 129.16 and its chemical formula is C9H7N. It is exceedingly stable and frequently employed as a high-boiling solvent (b.p. 237 °C), albeit it darkens when exposed to light. The acidic pKa is 4.85 and the logP value is 2.04. A weak tertiary base is quinoline. With acids, it can form a salt and exhibits reactions akin to those of pyridine and benzene. Both nucleophilic and electrophilic substitution reactions are shown. 6, 7, 8
Many naturally occurring physiologically active substances, such as quinine, chloroquine, bulaquine, primaquine, and tafenoquine from Cinchona alkaloids, include the quinoline core structure. 9 Typical drug design formulations make an effort to mimic naturally occurring heterocycles and exert potency by interfering with and interrupting the normal pathways required for the development of harmful organisms. Through their use as therapeutic agents, 10, 11, 12, 13 applications in human and veterinary medicine, 12 use in bioinformatics, 14 agriculture, 15, 16 polymers, 17 dyes, 18 and molecular engineering, 19 as well as their growing significance in numerous other fields, they have made a significant contribution to society.
NATURAL SOURCES OF QUINOLINES:
Quinoline may be obtained from a variety of natural sources, including animals, flowers, and microbes. Coal tar is the main source of quinoline. 21 Quinine, Quinidine, Cinchonine, and Cinchonidine are all found in Cinchona plant bark, which is compounded and used as "Quinimax" in the treatment of malaria. 22 A dimethoxylated quinoline molecule called nitidine, an anticancer drug, is derived from the citrus plant Zanthoxylum nitidum. Reticuline, an isoquinoline, is found naturally in a number of well-known medicinal plants, including opium species, Asimina triloba, Papaver somniferum, and Ocotea fasciculata. Sedative and anticonvulsant medications include the furoquinoline alkaloid known as skimmianine, which is found in Skimmia japonica. Nocardioides sp. contains the substance sanamycin, which has anticancer and antibacterial properties. It is a biomolecule with two 2-amidoquinoline molecules in its central structure. 23 The bark and stem of the Camptotheca acuminata tree can be used to extract camptothecin (a pentacyclic quinoline). The Dictamnus species may be used to isolate quinoline alkaloids. For instance, the plant Dictamnus angustifolius is the source of the quinoline alkaloid robustine, while Dictamnus albus is the source of evolitrin, a tricyclic quinoline, Dictamnus hispanicus is the source of ribalinidine, and Dictamnus dasycarpus and Dictamnus angustifolius are the sources of dictamnine. 24
SYNTHESIS OF QUINOLINE DERIVATIVES
1. The Skraup synthetic approach: 25
2. Friedlander Synthetic Approach: 26
3. Conrad–Limpach synthetic approach: 27
4. Doebner–Miller synthetic approach: 28
5. Vilsmeier–Haack reaction: 29
6. Pfitzinger synthetic approach: 30
APPLICATIONS OF QUINOLINE AND ITS DERIVATIVES
In general, it is generally recognised that quinoline derivatives have a wide range of uses in synthetic organic chemistry, pharmaceutical chemistry, bioorganic chemistry, and industrial chemistry. Numerous biological actions, including anti-malarial, anti-bacterial, anti-fungal, anti-asthmatic, anti-hypertensive, anti-inflammatory, and antiplatelet activity, have been discovered in their derivatives. 31 Additionally, they have anti-tubercular and immune-depressing properties. Some quinoline-ringed substances are showing promise as antimalarial medications, such as pamaquine, chloroquine, tafenoquine, bulaquine, quinine, and mefloquine, as well as amodiaquine, which has antimalarial and anti-inflammatory properties. 32-36 The oestrogen receptor b (ER b), which is crucial for the growth, upkeep, and operation of the mammalian reproductive system as well as in non-sexual tissues, is selectively binded to by the 2-arylquinoline derivatives. 37
Nitrogen at position 4 of 4-[2-(Diethylamino) ethylamino] quinolin-7-ol results in antiplasmodial action. [38] Metal complexes that emit light have been created using polysubstituted quinoline derivatives such 8-hydroxyquinoline and quinoline-8-thiol. 39 Sensors and light-emitting diodes have used 2-(4-Bromo-5-ethylnylthiophen-2-yl)-6-ethynyl-4-phenylquinoline. 40
With noticeable differences depending on the pattern of substitution, a novel family of hybrid conjugates of N-(7-chloroquinolin-4-yl) piperazine-1-carbothioamide and 1, 3, 5-triazine derivatives have significant antimalarial activity against both wild and mutant parasites. Against a variety of gram-positive and gram-negative pathogens, these compounds also exhibit remarkable antibacterial activity. 41, 42
The pathogenic parasite Toxoplasma gondii is resistant to the antiprotozoal effects of derivatives of 4-arylquinoline-2-carboxylate. 43 Numerous quinoline derivatives have been shown to be useful as agrochemicals 44 and in the research of bio-organic and bio-organometallic processes. 31 Additionally, they are employed in the production of organic molecules such as pH indicators, food colouring, and dyes. They have furthermore been employed as ligands to create OLED phosphorescent complexes 45 and with conjugated polymers as selective chemo-sensors for metal ions and fluoride. 46, 47
In hydrochloric acid, several quinoline derivatives, including quinalidine and quinaldic acid, have action as corrosion inhibitors for mild steel. 32 Recent years have seen the development of new Raf kinase inhibitors with more powerful and focused anticancer activity from quinoline derivatives that examined the structural alteration of sorafenib. 48 Strong antiplasmodial action is displayed by aziridine-isoquinoline combinations and their ring-opening derivatives. 49
CONCLUSION:
In the realm of medication research and discovery, quinoline and its analogues are extremely notable heterocyclic molecules. They represent a highly important class of scaffolds that are potentially found in nature and have a considerable impact on medicinal chemistry. The use of quinoline derivatives as therapeutic molecules to treat different diseases and infections has drawn increasing attention. From a current perspective, this is essential because we require an ecologically sound technique for the mass manufacture of a crucial biological component that can then be employed in a variety of processes to create an effective pharmacophore in the future.
ACKNOWLEDGEMENT:
The author is thankful to Mr. Rohit Kumar Bijauliya, Assistant Professor, BIU College of Pharmacy, Bareilly International University, Bareilly for their valuable guidance.
REFERENCES:
1. Shiro T, Fukaya T, Tobe M, "The chemistry and biological activity of heterocycle-fused quinoline derivatives: a review", Eur. J. Med. Chem., 2015; 97:397-408. https://doi.org/10.1016/j.ejmech.2014.12.004
2. Dutta C, Choudhury J, "C-H activation-annulation on the N-heterocyclic carbene platform". RSC advances. 2018; 8(49):27881-91. https://doi.org/10.1039/C8RA03799J
3. Bejan V, Mangalagiu II, "Benzo [f] quinoline: Synthesis and Structural Analysis". Rev Chim. 2011; 62:199-200.
4. Döbereiner JW. Döbereiner to Schönbein. In A History of Chemistry, Palgrave, London. 1964, pp. 178-198. https://doi.org/10.1007/978-1-349-00554-3_6
5. Ray RL, "Alkaloids-The world's pain killers". Journal of Chemical Education. 1960; 37(9):451. https://doi.org/10.1021/ed037p451
6. Basavarajaiah SM, Raviraj P, Nagesh GY, "A comprehensive review on the biological interest of quinoline and its derivatives". Bioorg. Med. Chem, 2021; 32:115973.
7. Ginsburg S, Wilson IB, "Oximes of the Pyridine Series1". Journal of the American Chemical Society. 1957; 79(2):481-5. https://doi.org/10.1021/ja01559a067
8. Zhang X, Campo MA, Yao T, Larock RC, "Synthesis of substituted quinolines by electrophilic cyclization of N-(2-alkynyl) anilines". Organic Letters. 2005; 7(5):763-6 https://doi.org/10.1021/ol0476218
9. Olateju OA, Babalola CP, Olubiyi OO, Kotila OA, Kwasi DA, Oaikhena AO and Okeke IN, "Quinoline antimalarials increase the antibacterial activity of ampicillin", Front. Microbiol., 2021; 12:556550. https://doi.org/10.3389/fmicb.2021.556550
10. Martins P, Jesus J, Santos S, Raposo LR, Roma- Rodrigues C, Baptista PV, Fernandes AR, "Heterocyclic anticancer compounds: recent advances and the paradigm shif towards the use of nanomedicine's tool box", Molecules, 2015; 20:16852-16891. https://doi.org/10.3390/molecules200916852
11. Qin SQ, Li LC, Song JR, Li HY, Li DP, "Structurally simple phenanthridine analogues based on nitidine and their antitumor activities", Molecules, 2019; 24:437. DOI: 10.3390/molecules24030437. https://doi.org/10.3390/molecules24030437
12. Patil V, Barragan E, Patil SA, Patil SA, Bugarin A, "Direct synthesis and antimicrobial evaluation of structurally complex chalcones", Chemistry Select, 2016; 1(13):3647-3650. https://doi.org/10.1002/slct.201600703
13. Vijayta G, Vinay K, "A review of biological activity of imidazole and thiazole moieties and their derivatives", Sci. Int., 2013; 1(7):253-260. https://doi.org/10.17311/sciintl.2013.253.260
14. Anna PN, Kirtee B, "Computer based drug design of various heterocyclic compounds having anticancer activity: a brief review", J. Bioinformat. Genom. Proteom., 2017; 2(1):1014.
15. Mohammed A, "A mini review: Biological significances of nitrogen heteroatom containing heterocyclic compounds", Int. J. Bioorg. Chem., 2017; 2(3):146-152.
16. Youness B, Younes Z, Jamal T, Ansar M, "Pyridazin- 3(2H)-ones: synthesis, reactivity, applications in pharmacology and agriculture", J. Chem. Pharm. Res., 2014; 6(12):297-310.
17. Emily AB, Timothy LE, "Imidazole- and imidazolium containing polymers for biology and material science applications", Polymer, 2010; 51(12):2447-2454. https://doi.org/10.1016/j.polymer.2010.02.006
18. Otutu JO, "Synthesis and application of azo dyes derived from 2-amino-1,3,4-thiadiazole-2-thiol on polyester", Int. J. Res. Rev. Appl. Sci., 2013; 15(2):292-296.
19. Chi-Shiang K, Chia-Chia F, Jia-Ying Y, Po-Jung T, Joseph PR, Chuan-Pin C and Yang-Hsiang C, Molecular engineering and design of semiconducting polymer dots with narrow-band, near-infrared emission for in vivo biological imaging, ACS Nano., 2017; 11(3):3166-3177.
20. Vaidya A, "Comprehensive review on current developments of quinoline-based anticancer agents", Arab. J. Chem., 2019; 12(8):4920-4946. https://doi.org/10.1016/j.arabjc.2016.10.009
21. Kannappan N, Reddy BS, Sen S, Nagarajan R and Dashpute S, "Synthesis and chemical characterization of quinoline imine derivatives", J. Appl. Chem. Res., 2009; 9:59-68.
22. Mistry B and Jauhari S, "Synthesis and characterization of some quinoline based azetidinones and thiazolidinones as antimicrobial agents", Sch. Res. Lib., 2010; 2(6):332-343.
23. Diaz G, Miranda IL and Diaz MA, "Quinolines, isoquinolines, angustereine, and congeneric alkaloids: Occurrence, chemistry, and biological activity in Phytochemicals Isolation, Characterization and Role in Human Health", Brazil, Intech, 2015; pp. 142-162. https://doi.org/10.5772/59819
24. Lv M, Xu P, Tian Y, Liang J, Gao Y, Xu F, Zhang Z and Sun J, "Medicinal uses, phytochemistry and pharmacology of the genus Dictamnus (Rutaceae)", J. Ethnopharmacol, 2015; 171:247-263. https://doi.org/10.1016/j.jep.2015.05.053
25. Chaturvedi D, "Ionic liquids: A class of versatile green reaction media for the syntheses of nitrogen heterocycles". Current Organic Synthesis. 2011; 8(3):438-71. https://doi.org/10.2174/157017911795529092
26. Cheng C, Yan SJ, The Friedlander synthesis of quinoline, in Organic Reactions, vol. 28, John Wiley and Sons, London, 1982, pp. 37-39. https://doi.org/10.1002/0471264180.or028.02
27. Bergstrom FW, "Heterocyclic Nitrogen Compounds. Part IIA. Hexacyclic Compounds: Pyridine, Quinoline, and Isoquinoline:. Chemical Reviews. 1944; 35(2):77-277. https://doi.org/10.1021/cr60111a001
28. Madapa S, Tusi Z, Batra S, "Advances in the syntheses of quinoline and quinoline-annulated ring systems", Curr. Org. Chem., 2008; 12:1116-1183.
https://doi.org/10.2174/138527208785740300
29. Becker A, Kohfeld S, Pies T, Wieking K, Preu L and Kunick C, "Synthesis of 11H-indolo[3,2-c]quinoline-6-carboxylic acids by cascade autoxidation-ring contractions", Synthesis, 2009; 7:1185-1189. https://doi.org/10.1055/s-0028-1088014
30. Ivachtchenko AV, Khvat AV, Kobak VV, Kysil VM, Williams CT, "A new insight into the Pfitzinger reaction. A facile synthesis of 6-sulfamoylquinoline-4-carboxylic acids". Tetrahedron letters. 2004; 45(28):5473-6. https://doi.org/10.1016/j.tetlet.2004.05.028
31. Desai U, Mitragotri S, Thopate T, Pore D and Wadgaonkarb P, ARKIVOC, 2006; 198-204. https://doi.org/10.3998/ark.5550190.0007.f24
32. Ebenso EE, Kabanda MM, Arslan T, Saracoglu M, Kandemirli F, Murulana LC, A. K. Singh, S. K. Shukla, Turk. J. Chem., 2001; 06, 54-67.
33. Hammouti B and Khaled K, Int. J. Electrochem. Sci., 2012; 7:5643-5676.
34. Bawa S, Kumar S, Drabu S, Kumar R, J. Pharm. BioAllied Sci., 2010; 2:64-71. https://doi.org/10.4103/0975-7406.67002
35. Ozyanik M, Demirci S, Bektas H, Demirbas N, Demirbas A, Karaoglu SA, Turk. J. Chem., 2012; 36:233-246.
36. Graves PR, Kwiek JJ, Fadden P, Ray R, Hardeman K, Coley AM, Foley M, Haystead TA, Mol. Pharmacol., 2002; 62:1364-1372. https://doi.org/10.1124/mol.62.6.1364
37. Vu AT, Cohn ST, Manas ES, Harris HA, Mewshaw RE, Bioorg. Med. Chem. Lett., 2005; 15:4520-4525. https://doi.org/10.1016/j.bmcl.2005.07.008
38. Kaschula CH, Egan TJ, Hunter R, Basilico N, Parapini S, Taramelli D, Pasini E, Monti D, J. Med. Chem., 2002; 45:3531-3539. https://doi.org/10.1021/jm020858u
39. Tokoro Y, Nagai A, Kokado K, Chujo Y, Macromolecules, 2009; 42:2988-2993. https://doi.org/10.1021/ma900008m
40. J'egou G, Jenekhe SA, Macromolecules, 2001; 34:7926-7928. https://doi.org/10.1021/ma0111562
41. Bhat HR, Singh UP, Gahtori P, Ghosh SK, Gogoi K, Prakash A, Singh RK, RSC Adv., 2013; 3:2942. https://doi.org/10.1039/c2ra21915h
42. Bhat HR, Gupta SK, Singh UP, RSC Adv., 2012; 2:12690. https://doi.org/10.1039/c2ra22353h
43. McNulty J, Vemula R, Bordon C, Yolken R, Jones- Brando L, Org. Biomol. Chem., 2014; 12:255-260. https://doi.org/10.1039/C3OB41539B
44. Gogoi S, Shekarrao K, Duarah A, Bora TC, Boruah RC, Steroids, 2012; 77:1438-1445. https://doi.org/10.1016/j.steroids.2012.08.008
45. Kwong R, J. Am. Chem. Soc., 2005; 127:1614-1615. https://doi.org/10.1021/ja043721x
46. Tong H, Wang L, Jing X and Wang F, Macromolecules, 2003; 36:2584-2586. https://doi.org/10.1021/ma0258612
47. Tumambac GE, Rosencrance CM, Wolf C, Tetrahedron, 2004; 60:11293-11297. https://doi.org/10.1016/j.tet.2004.07.053
48. Li Y, Shi X, Xie N, Zhao Y, Li S, Med Chem Comm, 2013; 4: 367.
49. Vandekerckhove S, De Moor S, Segers D, de Kock C, Smith PJ, Chibale K, De Kimpe N, D'Hooghe M, Med Chem Comm, 2013; 4:724. https://doi.org/10.1039/c3md20377h